The content on this site is intended for healthcare professionals only
Sherwin Criseno speaks to ecancer at UKONS 2019 in Telford about navigating the endocrinopathy puzzle in patients receiving immunotherapy.
Criseno explains that endocrinopathy is poorly understood in the field of immunotherapy due to it being quite rare and the presentation of patients receiving immunotherapy can be vague. He outlines the case study discussed in his session and some of the red flags they managed to recognise.
He also proposes ways for the management of these patients to improve - including education, networking and looking at best practice elsewhere.
Cancer in emergencies: What can we do better to protect the most vulnerable?
Multiple Myeloma: evolving paradigm - Panel Discussion
Patient expectations and shared decision making in aRCC
Grand Rounds: Improving quality of patient-centred care
CAR-T therapy and impact to cancer patient outcomes and experience of treatment
A reproducibility study in pulmonary adenocarcinomas supports a revised classification
Reducing stigma for lung cancer and other smoking-related respiratory diseases
Supporting breast cancer patients in Vietnam
Neo-adjuvant therapy for different cancers in the Philippines
